Currently, there are only two cell and gene therapies (CGTs) on the market across all gastroenterology (GI) indications. Anterogen's Cupistem, indicated for the treatment of anal fistula in adult ...
New research explores the potential of adipose-derived stem cells to reduce fibrosis and modulate the immune system in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback